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Background: Human cerebral small vessel disease (CSVD) has distinct histopathologic and imaging findings in its
advanced stages. In spontaneously hypertensive stroke-prone rats (SHRSP), a well-established animal model of
CSVD, we recently demonstrated that cerebral microangiopathy is initiated by early microvascular dysfunction
leading to the breakdown of the blood–brain barrier and an activated coagulatory state resulting in capillary and
arteriolar erythrocyte accumulations (stases). In the present study, we investigated whether initial microvascular
dysfunction and other stages of the pathologic CSVD cascade can be detected by serial magnetic resonance
imaging (MRI).
Findings: Fourteen SHRSP and three control (Wistar) rats (aged 26–44 weeks) were investigated biweekly by 3.0
Tesla (3 T) MRI. After perfusion, brains were stained with hematoxylin–eosin and histology was correlated with MRI
data. Three SHRSP developed terminal CSVD stages including cortical, hippocampal, and striatal infarcts and
macrohemorrhages, which could be detected consistently by MRI. Corresponding histology showed small vessel
thromboses and increased numbers of small perivascular bleeds in the infarcted areas. However, 3 T MRI failed to
visualize intravascular erythrocyte accumulations, even in those brain regions with the highest densities of affected
vessels and the largest vessels affected by stases, as well as failing to detect small perivascular bleeds.
Conclusion: Serial MRI at a field strength of 3 T failed to detect the initial microvascular dysfunction and
subsequent small perivascular bleeds in SHRSP; only terminal stages of cerebral microangiopathy were reliably
detected. Further investigations at higher magnetic field strengths (7 T) using blood- and flow-sensitive sequences
are currently underway.
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Human cerebral small vessel disease (CSVD), a major cause
of stroke-like symptoms and dementia, is associated with
lacunar infarcts, lacunes, microbleeds, enlarged perivascular
spaces, white matter lesions of the cerebral and cerebellar
hemispheres, and primary intracerebral hemorrhages [1,2].* Correspondence: stefanie.schreiber@med.ovgu.de
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reproduction in any medium, provided the orThese are associated with distinct histopathologic and
imaging findings in advanced and terminal stages of the
disease. To what extent the underlying histopathology
(including degenerative small vessel wall changes and the
presence of trabeculated cavities surrounded by gliosis with
small vessel occlusions and wall enlargements [3,4]), corre-
sponds to imaging findings remains unclear.
We have recently conducted several longitudinal stu-
dies using spontaneously hypertensive stroke-prone rats
(SHRSP), an animal model that is widely accepted to be
the most valid model of human CSVD [1,5,6], and foundtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Cortical and hippocampal small vessel thromboses, small perivascular bleeds, infarcts, and macrohemorrhages in
spontaneously hypertensive stroke-prone rats (SHRSP). T2-weighted (T2w) sequences (A, distance from bregma −5 mm) and hematoxylin–
eosin staining (B) with coronal slice orientation performed at the age of 30 weeks in SHRSP K1R1 showed bilateral cortical and hippocampal
infarcts (dashed outline in A, B) as well as macrohemorrhages (black arrowheads in A, B). The corresponding histology displayed small vessel
thromboses (black arrowheads in C) and a high number of small perivascular bleeds within the infarcted areas (exemplary ones marked with
black arrowheads in D). w – age in weeks; Scale bar in B: 1000 μm; Scale bar in C and D: 50 μm.
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function that ultimately leads to a breakdown in the blood–
brain barrier, an activated coagulatory state, and an
intraluminal accumulation of erythrocytes that are visible
as “stases” using conventional histology [7-11]. The result-
ant increasing vessel wall fragility leads to small perivascu-
lar bleeds and reactive (complete) hyaline fibrin thromboses
with associated infarcts [7].
The aim of our current study was to investigate whether
stases (or associated phenomena), which are indicative of
early microvascular dysfunction in SHRSP, are detectable
using 3.0 Tesla (3 T) MRI. This imaging technique has
been used previously in rat studies [12] and is employed
as a standard diagnostic in the clinical setting.Figure 2 Serial brain magnetic resonance imaging (MRI) revealed infa
stroke-prone rats (SHRSP). T2-weighted (T2w) sequences (A–D) with coro
(A, B, DfB 0.7 mm, −2.3 mm) and 34 weeks (C, D, DfB 0.5 mm, −2.6 mm) in
with midline shift (D) over time. Both MRI scans and the corresponding his
in B–F). Histology revealed a high number of small perivascular hemorrhag
w – age in weeks; DfB – distance from bregma; Scale bar in E and F: 1000Materials and methods
All animal procedures were approved by the local Ethical
Committees in accordance with the animal protection
guidelines and European Communities Council guidelines
(55.2-2531.01-74/11; 42502-2-1148 DZNE). Fourteen male
SHRSP and 3 control Wistar rats (Charles River Laborato-
ries International Inc., Wilmington, MA, USA) underwent
biweekly 3 T MRI (Siemens MAGNETOM Trio, Erlangen,
Germany) from the age of 26 weeks. Animals were anes-
thetized (2% isoflurane), and respiratory frequency and
body temperature were monitored. Imaging was performed
using a 4-channel array rat head coil (RAPID Biomedical,
Rimpar, Germany) with the following sequences/protocols:
T1-weighted (w) (repetition time (TR) 700 ms, echo timerct progression within 2 weeks in spontaneously hypertensive
nal slice orientation were performed at the age of 32 weeks
SHRSP K2R2 and revealed an infarct progression in the basal ganglia
tology (E, F) showed a nearly panhemispheric infarct (dashed outline
es (G) and small vessel thromboses in the infarcted area (H).
μm. Scale bar in G and H: 50 μm.
Figure 3 Infarct progression and macrohemorrhages in spontaneously hypertensive stroke-prone rats (SHRSP). T2-weighted (T2w)
sequences (A–D) with coronal slice orientation were performed at the age of 40 weeks (A, B, DfB −7.3 mm, −5.6 mm) and 42 weeks
(C, D, DfB −6.5 mm, −6.1 mm) in SHRSP K1R2 revealed a progression of bilateral cortical infarcts (dashed outline in A–D) and the embedded
macrohemorrhage (black arrowheads in B, D) within 2 weeks. Histology showed a high number of small perivascular bleeds (E) and small
thromboses in the infarcted area (F). w – age in weeks; DfB – distance from bregma. Scale bar in E–G: 50 μm.
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lution 0.2 × 0.2 mm), T2w (TR 4900 ms, TE 110 ms, SLT
1.0 mm, in plane resolution 0.1 × 0.1 mm), T2w constructive
interference in steady-state three-dimension (CISS 3D; TR
8.8 ms, TE 3.8 ms, SLT 0.3 mm, in plane resolution 0.3 ×
0.3 mm), fluid-attenuated inversion recovery (FLAIR; TR
7500 ms, TE 90 ms, inversion time 2100 ms, flip angle (FA)
150°, SLT 2.0 mm, in plane resolution 0.2 × 0.2 mm), gradi-
ent echo (GRE; TR 21 ms, TE 6.1 ms, FA 25°, SLT 1.0 mm,
in plane resolution 0.2 × 0.2 mm). MRIs were assessed quali-
tatively by an experienced neuroradiologist (G.H.).Figure 4 No pathology on magnetic resonance imaging in spontaneo
T1-weighted (T1w; A), T2-weighted (T2w; B), T2 constructive interference in
sequences with coronal slice orientation performed at the age of 34 weeks
34 weeks displayed arteriolar stases in the cortex (E) and capillary stases in
Scale bar in E and F: 50 μm.The rats were transcardially perfused when they showed
evidence of anxiety, aggression, decreased spontaneous
activity, moving deficits, coordination failure, falling to one
side, or weight loss (>10% weekly), or at an age of 44 weeks.
Perfusion was performed with 120 ml phosphate-buffered
saline, followed by 120 ml of 4% paraformaldehyde (PFA);
brains were removed, fixed in 4% PFA for 48 h at 4°C and
placed for cryoprotection for 6 days into 30% sucrose be-
fore being frozen in methylbutane at −80°C. Coronal slices
(30 μm, 30–33 slices per animal) of the whole brains of
all animals who underwent MRI and six additional Wistarusly hypertensive stroke-prone rats (SHRSP) with only stases.
steady state (C) and T2 gradient echo (D) (A–D: DfB −3.2 mm)
in SHRSP K2R3 showed no abnormal findings. Histology at the age of
the hippocampus (F). w – age in weeks; DfB – distance from bregma.
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eosin, and the density of vessels affected by stases (given as
mean out of 50 fields of view (FoV) per brain region,
magnification × 200) and the occurrence and extent of
perivascular small bleeds, thromboses/associated in-
farcts, and macrohemorrhages were assessed in all
brain regions including the basal ganglia, thalamus,
cortical regions, hippocampus, and corpus callosum.
Additionally, the luminal diameter of the small vessels
affected by stases and the diameter of all bleeds were
measured.Results
Three of the 14 SHRSP investigated exhibited T2w
hyperintensities, predominantly localized in the parietal
cortex, basal ganglia, and hippocampus, indicating infarcts
first detectable on MRI at the ages of 30, 32, and 40 weeks
(Figures 1, 2 and 3) and extending over approximately
2 weeks (Figures 2 and 3). In two of these SHRSP, cortical
(2200 μm diameter (Figure 1) and 1100 μm diameter
(Figure 3)) and hippocampal (1600 μm diameter (Figure 1))
macrohemorrhages were embedded between the T2w
hyperintensities. The MRI data were confirmed by his-
tology, demonstrating small vessel thromboses with evi-
dence of stases in the infarcted regions of the three
SHRSP (Figures 1, 2 and 3). Compared with the SHRSP
without infarcts/macrohemorrhages (1–25 small perivas-
cular bleeds per animal), up to a 20-fold higher number of
small perivascular bleeds (75–510 per animal) were
detected in the infarcted regions (Figures 1, 2 and 3).
However, only two of these three SHRSP showed weight
loss and behavior changes, while one (Figure 3) was free
from any of these symptoms. One SHRSP developed be-
havior abnormalities and weight loss without any detec-
table MRI pathology; histology revealed only a few stases,
predominantly in the cortical (0.56 per FoV) and hippo-
campal (0.40 per FoV) capillary bed and in the cortical,
and striatal arterioles (0.44 per FoV; Figure 4).
The remaining SHRSP (n = 10) and all investigated
Wistar control rats showed no MRI pathologies, no be-
havior abnormalities/weight loss and no thromboses/in-
farcts or macrohemorrhages. The histology of these rats
revealed capillary (mean: 4.5 per FoV per animal) and, to
a far lesser extent, arteriolar stases (mean: 0.08 per FoV
per animal) in all investigated brain regions; however,
even in animals with the highest density of vessels with
capillary (22.18 per FoV per animal) or arteriolar (0.36
per FoV per animal) stases, no MRI abnormalities were
detectable and the diameter of the affected small vessels
did not exceed 60 μm. In nine of these 10 SHRSP (90%)
and four of the nine controls (44%), small perivascular
bleeds with a maximal diameter of 360 μm (SHRSP) or
125 μm (Wistar rats), respectively, were verifiable in allinvestigated brain regions; most of these small bleeds
did not exceed a diameter of 50 μm.
In conclusion, 3 T MRI effectively detected infarcts and
macrohemorrhages exceeding 800 μm in diameter in
SHRSP, but failed to detect small perivascular bleeds and
arterial stases in SHRSP and controls. Behavior changes
and weight loss were unreliable predictors of small peri-
vascular bleeds and stases in this study; a finding that re-
quires further evaluation in a larger cohort of animals.
The burden and increasing diameter of small perivascular
bleeds in infarcted regions support our concept of a
pathologic cascade of CSVD in SHRSP [13]. Further inves-
tigations at higher magnetic field strengths (7 T) using
blood- and flow-sensitive sequences are currently under-
way to increase the diagnostic sensitivity of this MRI tech-
nique for early microvascular dysfunction.
Abbreviations
CSVD: Cerebral small vessel disease; CISS 3D: Constructive interference in
steady-state three-dimension; DfB: Distance from bregma; FA: Flip angle;
FLAIR: Fluid-attenuated inversion recovery; FoV: Field of view; GRE: Gradient
echo; MRI: Magnetic resonance imaging; PFA: Paraformaldehyde;
SHRSP: Spontaneously hypertensive stroke-prone rats; SLT: Slice thickness;
T: Tesla; T1w: T1-weighted; T2w: T2-weighted; TE: Echo time; TR: Repetition
time.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SS directed the study, designed experiments, analyzed data and drafted the
manuscript; SM designed and performed experiments, analyzed data, and
drafted the manuscript; CG and HB designed and performed experiments,
analyzed data, and made major contributions to the manuscript writing;
EG designed and performed experiments; SN performed experiments; GH
provided specific input to MRI experiments including experimental design
and contributed to the manuscript writing; CK, HJH, and KGR funded the
study, designed experiments and contributed to manuscript writing. All
authors read and approved the final manuscript.
Acknowledgements
This publication was funded by the German Research Foundation (DFG) and
the University of Wuerzburg in the funding programme Open Access
Publishing.
Author details
1Department of Neurology, University Hospital of Würzburg, Würzburg,
Germany. 2Department of Neurology, Otto-von-Guericke-University,
Magdeburg, Germany. 3Leibniz Institute for Neurobiology, Magdeburg,
Germany. 4German Center for Neurodegenerative Diseases (DZNE),
Magdeburg, Germany. 5Department of Neuroradiology, University Hospital of
Würzburg, Würzburg, Germany.
Received: 21 June 2013 Accepted: 21 June 2013
Published: 25 June 2013
References
1. Wardlaw JM, Smith C, Dichgans M: Mechanisms of sporadic cerebral small
vessel disease: insights from neuroimaging. Lancet Neurol 2013, 12:483–497.
2. Lammie GA: Pathology of small vessel stroke. Br Med Bull 2000, 56:296–306.
3. Grinberg LT, Thal DR: Vascular pathology in the aged human brain.
Acta Neuropathol 2010, 119:277–290.
4. Fisher CM: The arterial lesions underlying lacunes. Acta Neuropathol 1968,
12:1–15.
Mencl et al. Experimental & Translational Stroke Medicine 2013, 5:8 Page 5 of 5
http://www.etsmjournal.com/content/5/1/85. Hainsworth AH, Markus HS: Do in vivo experimental models reflect
human cerebral small vessel disease? A systematic review. J Cereb Blood
Flow Metab 2008, 28:1877–1891.
6. Bailey EL, McCulloch J, Sudlow C, Wardlaw JM: Potential animal models of
lacunar stroke: a systematic review. Stroke 2009, 40:e451–e458.
7. Schreiber S, Bueche CZ, Garz C, Kropf S, Angenstein F, Goldschmidt J,
Neumann J, Heinze HJ, Goertler M, Reymann KG, Braun H: The pathologic
cascade of cerebrovascular lesions in SHRSP: is erythrocyte accumulation
an early phase? J Cereb Blood Flow Metab 2012, 32:278–290.
8. Braun H, Bueche CZ, Garz C, Oldag A, Heinze HJ, Goertler M, Reymann KG,
Schreiber S: Stases are associated with blood–brain barrier damage and a
restricted activation of coagulation in SHRSP. J Neurol Sci 2012, 322:71–76.
9. Schreiber S, Garz C, Bueche C, Kuester D, Kropf S, Westphal S, Isermann B,
Oldag A, Heinze HJ, Goertler M, et al: Do basophile structures as age
dependent phenomenon indicate small vessel wall damage?
Microvasc Res 2012, 84:375–377.
10. Schreiber S, Bueche CZ, Garz C, Braun H: Blood brain barrier breakdown as
the starting point of cerebral small vessel disease? - New insights from a
rat model. Exp Transl Stroke Med 2013, 5:4.
11. Bueche CZ, Garz C, Kropf S, Bittner D, Li W, Goertler M, Heinze HJ, Reymann
K, Braun H, Schreiber S: NAC changes the course of cerebral small vessel
disease in SHRSP and reveals new insights for the meaning of stases -
a randomized controlled study. Exp Transl Stroke Med 2013, 5:5.
12. Kleinschnitz C, Schutz A, Nolte I, Horn T, Frank M, Solymosi L, Stoll G,
Bendszus M: In vivo detection of developing vessel occlusion in
photothrombotic ischemic brain lesions in the rat by iron particle
enhanced MRI. J Cereb Blood Flow Metab 2005, 25:1548–1555.
13. Braun H, Schreiber S: Comment to the review “Mechanisms of sporadic
cerebral small vessel disease: insights from neuroimaging” published by
Wardlaw JM, Smith C, Dichgans M. Lancet Neurol. Lancet Neurol 2013,
12:483–497. in Press.
doi:10.1186/2040-7378-5-8
Cite this article as: Mencl et al.: Early microvascular dysfunction in
cerebral small vessel disease is not detectable on 3.0 Tesla magnetic
resonance imaging: a longitudinal study in spontaneously hypertensive
stroke-prone rats. Experimental & Translational Stroke Medicine 2013 5:8.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
